Bellevue Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-149,113
| Closed | -$9.52M | – | 152 |
|
2025
Q1 | $9.52M | Sell |
149,113
-22,204
| -13% | -$1.42M | 0.21% | 77 |
|
2024
Q4 | $20.8M | Sell |
171,317
-173,031
| -50% | -$21M | 0.4% | 61 |
|
2024
Q3 | $43M | Buy |
344,348
+92,027
| +36% | +$11.5M | 0.7% | 39 |
|
2024
Q2 | $39.9M | Buy |
252,321
+800
| +0.3% | +$126K | 0.65% | 44 |
|
2024
Q1 | $32.6M | Buy |
251,521
+14,235
| +6% | +$1.84M | 0.5% | 61 |
|
2023
Q4 | $22.9M | Sell |
237,286
-4,466
| -2% | -$431K | 0.35% | 71 |
|
2023
Q3 | $29.3M | Buy |
241,752
+41,532
| +21% | +$5.03M | 0.47% | 63 |
|
2023
Q2 | $22.9M | Sell |
200,220
-446,394
| -69% | -$51.1M | 0.33% | 70 |
|
2023
Q1 | $89.1M | Sell |
646,614
-46,595
| -7% | -$6.42M | 1.29% | 20 |
|
2022
Q4 | $89.8M | Sell |
693,209
-62,689
| -8% | -$8.12M | 1.19% | 24 |
|
2022
Q3 | $83.6M | Sell |
755,898
-383,557
| -34% | -$42.4M | 1.2% | 27 |
|
2022
Q2 | $85.4M | Sell |
1,139,455
-11,704
| -1% | -$877K | 1.21% | 24 |
|
2022
Q1 | $89.9M | Buy |
1,151,159
+324,418
| +39% | +$25.3M | 1.04% | 33 |
|
2021
Q4 | $74.4M | Buy |
826,741
+257,573
| +45% | +$23.2M | 0.77% | 44 |
|
2021
Q3 | $52.6M | Buy |
+569,168
| New | +$52.6M | 0.53% | 61 |
|
2021
Q2 | – | Sell |
-20,300
| Closed | -$1.51M | – | 222 |
|
2021
Q1 | $1.51M | Hold |
20,300
| – | – | 0.02% | 149 |
|
2020
Q4 | $3.46M | Hold |
20,300
| – | – | 0.04% | 132 |
|
2020
Q3 | $2.85M | Hold |
20,300
| – | – | 0.04% | 138 |
|
2020
Q2 | $3.26M | Buy |
20,300
+300
| +2% | +$48.1K | 0.05% | 128 |
|
2020
Q1 | $1.96M | Buy |
20,000
+4,500
| +29% | +$440K | 0.04% | 129 |
|
2019
Q4 | $2M | Buy |
+15,500
| New | +$2M | 0.03% | 131 |
|
2019
Q2 | – | Sell |
-9,100
| Closed | -$1.09M | – | 213 |
|
2019
Q1 | $1.09M | Sell |
9,100
-3,600
| -28% | -$429K | 0.06% | 125 |
|
2018
Q4 | $1.39M | Sell |
12,700
-400
| -3% | -$43.7K | 0.09% | 104 |
|
2018
Q3 | $2.12M | Buy |
+13,100
| New | +$2.12M | 0.13% | 103 |
|